Beauty Expo 2026: AI Moves From Hype to Hard Productivity, Compliance Tightens, and “Mind‑Body” Beauty Goes Mainstream

Expo sets the tone: innovation, winnowing and a new cycle

The 2026 Beauty Expo — China’s annual industry barometer — made one thing clear: the Chinese beauty industry has left the “wild growth” era and entered a maturity phase defined by innovation, cost discipline and compliance. It has been reported that 2025 saw 52 new Class III medical device approvals, breaking the old scarcity model that underpinned sky‑high valuations for firms such as HuaXi Biotech (华熙生物), Aimeike (爱美客) and Haohai Bio (昊海生科). Who benefits when product approval is no longer a moat? The answer: companies that can innovate, cut costs and operate at scale.

AI: from auxiliary gadget to core production tool

One dominant theme at the show was AI’s rapid march from marketing gimmick to operational backbone. Exhibitors showcased AI‑driven skin‑analysis models, shop management systems that recommend promotions from live sales data, and service robots that standardize repetitive tasks — all designed to reduce headcount and improve repeatable outcomes. Reportedly, manufacturers are prioritizing AI features in devices to meet outlets’ demand for measurable effects and lower labor costs, while core clinical procedures such as injectables remain human‑led for now as models confront safety, accuracy and “hallucination” risks.

Compliance tightens and channels shift

Regulatory pressure is reshaping go‑to‑market models. Platforms such as Xiaohongshu (小红书) have tightened forbidden categories and raised bond requirements, and China’s new Live‑Stream E‑commerce Supervision Measures (直播电商监督管理办法) have further clipped influencer‑led, high‑hype sales of medical beauty items — items that regulators now treat as advertising. It has been reported that these moves, together with higher exhibitor costs, help explain many international brands’ reduced presence at the expo; some absences reportedly reflect corporate caution amid global economic uncertainty and recalibrated supply‑chain and trade dynamics.

Demand shifts: health and emotion join aesthetics; specialization wins

Beyond tech and rules, the consumer story is changing: beauty is becoming “health plus emotion.” The expo’s mouthful‑less zones — oral supplements, scalp therapy, aromatherapy, moxibustion and stress‑relief devices — were packed. Chinese consumers, increasingly safety‑conscious and stress‑aware, are paying premiums for products that promise measurable health or mood benefits. The winners will likely be firms that combine certified safety and R&D depth with niche, personalized offers — a shift that favors professionalization over the old information‑arbitrage playbook.